Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CD2BP2 Biologics Sequence Review Report 2026: CD2 antigen cytoplasmic tail-binding protein 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD2BP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD244 Biologics Sequence Review Report 2026: Natural killer cell receptor 2B4 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD244 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD226 Biologics Sequence Review Report 2026: CD226 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD226 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD209 Biologics Sequence Review Report 2026: CD209 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD209 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD1D Biologics Sequence Review Report 2026: Antigen-presenting glycoprotein CD1d Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD1C Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1c Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD1B Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1b Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD177 Biologics Sequence Review Report 2026: CD177 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD177 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD151 Biologics Sequence Review Report 2026: CD151 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD14 Biologics Sequence Review Report 2026: Monocyte differentiation antigen CD14 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL28 Biologics Sequence Review Report 2026: C-C motif chemokine 28 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL27 Biologics Sequence Review Report 2026: C-C motif chemokine 27 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
494
495
496
497
498
>>
1905
>